- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2008-007995-81.
Displaying page 1 of 1.
EudraCT Number: 2008-007995-81 | Sponsor Protocol Number: VX08-950-110 | Start Date*: 2010-04-28 | ||||||||||||||||
Sponsor Name:Vertex Pharmaceuticals Incorporated | ||||||||||||||||||
Full Title: A Phase 2a, 2-Part, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Study of Telaprevir in Combination with Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Su... | ||||||||||||||||||
Medical condition: chronic hepatitis c virus genotype 1 infection human immunodeficiency virus genotype 1 infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) FR (Completed) ES (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
![](img/rss.png)
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
![](img/info.png)